These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8991899

  • 1. [Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women].
    Gaspard UJ.
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):671-6. PubMed ID: 8991899
    [Abstract] [Full Text] [Related]

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 3. Oestrogens and the heart.
    Rosano GM, Panina G.
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM, Vitale C, Fini M.
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [Abstract] [Full Text] [Related]

  • 5. Postmenopausal hormone replacement therapy and cardiovascular disease.
    Chae CU, Ridker PM, Manson JE.
    Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254
    [Abstract] [Full Text] [Related]

  • 6. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M.
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [Abstract] [Full Text] [Related]

  • 7. [Hormone replacement therapy and cardiovascular risk in menopausal women].
    Simon T, Jaillon P.
    Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551
    [Abstract] [Full Text] [Related]

  • 8. [Hormone replacement therapy and cardiovascular risk].
    Maffei S, De Caterina R.
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [Abstract] [Full Text] [Related]

  • 9. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M.
    Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
    [Abstract] [Full Text] [Related]

  • 10. [Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease].
    Stehouwer CD.
    Ned Tijdschr Geneeskd; 2001 Jan 13; 145(2):61-4. PubMed ID: 11225257
    [Abstract] [Full Text] [Related]

  • 11. [Hormone replacement therapy in postmenopausal women and cardiovascular risk].
    Karam C, Bourmayan C, Desnos M, Guérot C.
    Ann Cardiol Angeiol (Paris); 1995 Apr 13; 44(4):195-201. PubMed ID: 7632028
    [Abstract] [Full Text] [Related]

  • 12. [Cardiovascular risk and hormone replacement therapy in menopause].
    Plu-Bureau G.
    Therapie; 1999 Apr 13; 54(3):375-80. PubMed ID: 10500454
    [Abstract] [Full Text] [Related]

  • 13. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group.
    Hum Reprod Update; 2006 Apr 13; 12(5):483-97. PubMed ID: 16807276
    [Abstract] [Full Text] [Related]

  • 14. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM, Maffei S, Andreassi MG, Vitale C, Vassalle C, Gambacciani M, Stramba-Badiale M, Mercuro G.
    J Cardiovasc Med (Hagerstown); 2009 Jan 13; 10(1):85-92. PubMed ID: 19145119
    [Abstract] [Full Text] [Related]

  • 15. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.
    J Endocrinol Invest; 2005 Jan 13; 28(10 Suppl):80-4. PubMed ID: 16550729
    [Abstract] [Full Text] [Related]

  • 16. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL.
    J Reprod Med; 2000 Mar 13; 45(3 Suppl):259-73. PubMed ID: 10756507
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM, Naftolin F, Brinton EA, Judelson DR.
    Ann N Y Acad Sci; 2005 Jun 13; 1052():43-56. PubMed ID: 16024750
    [Abstract] [Full Text] [Related]

  • 19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 13; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 20. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 13; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.